Physician profile
Peter Higgins
NPI 1700866142
$3,760.65
in general payments reported to CMS, 2019-2025
12 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $747 · 2020: $41.60 · 2021: $210 · 2022: $1,241 · 2023: $1,301 · 2024: $61.32 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,173 · Travel and Lodging: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,172.70 |
| Travel and Lodging | $348.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,382.79 | 2019-2022 | |
| Edwards Lifesciences Corporation | $965.02 | 2019-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Abbott Laboratories | $756.34 | 2019-2025 | Triclip, Pressurewire |
| Teleflex LLC | $216.41 | 2023 | Turnpike, Guideliner |
| Abiomed | $146.80 | 2021-2023 | Impella |
| Shockwave Medical, INC | $92.50 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biotronik INC. | $81.71 | 2023 | Orsiro Mission |
| Medtronic Vascular, INC. | $41.60 | 2020 | |
| Medtronic, INC. | $26.50 | 2021 | |
| Penumbra, INC. | $20.45 | 2021 | |
| Abbvie INC. | $18.58 | 2022 | |
| Astellas Pharma US INC | $11.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Higgins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.